192 related articles for article (PubMed ID: 18391115)
1. Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography.
Aziz K; Berger K; Claycombe K; Huang R; Patel R; Abela GS
Circulation; 2008 Apr; 117(16):2061-70. PubMed ID: 18391115
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of atherosclerosis evolution by detection of inflammatory states of aortae in a rabbit model using 18F-FDG -PET/CT.
Zhao QM; Zhao X; Feng TT; Zhang MD; Zhuang XC; Zhao XC; Zhang XX; Su G
Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):440-50. PubMed ID: 24518191
[TBL] [Abstract][Full Text] [Related]
3. [Noninvasive imaging of vulnerable plaques and thromboses with PET/CT complex imaging technique].
Zhao X; Zhao QM; Feng TT; Li DP; Liu Y; Li LQ; Zhang MD; Zhuang XC; Zhao XC
Zhonghua Yi Xue Za Zhi; 2013 May; 93(19):1454-7. PubMed ID: 24029566
[TBL] [Abstract][Full Text] [Related]
4. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
[TBL] [Abstract][Full Text] [Related]
5. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology.
Hyafil F; Cornily JC; Rudd JH; Machac J; Feldman LJ; Fayad ZA
J Nucl Med; 2009 Jun; 50(6):959-65. PubMed ID: 19443582
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography.
Tawakol A; Migrino RQ; Hoffmann U; Abbara S; Houser S; Gewirtz H; Muller JE; Brady TJ; Fischman AJ
J Nucl Cardiol; 2005; 12(3):294-301. PubMed ID: 15944534
[TBL] [Abstract][Full Text] [Related]
7. Detection of vulnerable atherosclerotic plaque and prediction of thrombosis events in a rabbit model using 18F-FDG -PET/CT.
Zhao QM; Zhao X; Feng TT; Zhang MD; Zhuang XC; Zhao XC; Li LQ; Li DP; Liu Y
PLoS One; 2013; 8(4):e61140. PubMed ID: 23613798
[TBL] [Abstract][Full Text] [Related]
8. Plaque Thrombosis is Reduced by Attenuating Plaque Inflammation with Pioglitazone and is Evaluated by Fluorodeoxyglucose Positron Emission Tomography.
Zhang MD; Zhao XC; Zhang YH; Yan YF; Wang ZM; Lv SZ; Zhao QM
Cardiovasc Ther; 2015 Jun; 33(3):118-26. PubMed ID: 25825053
[TBL] [Abstract][Full Text] [Related]
9. Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis.
Ye YX; Calcagno C; Binderup T; Courties G; Keliher EJ; Wojtkiewicz GR; Iwamoto Y; Tang J; Pérez-Medina C; Mani V; Ishino S; Johnbeck CB; Knigge U; Fayad ZA; Libby P; Weissleder R; Tawakol A; Dubey S; Belanger AP; Di Carli MF; Swirski FK; Kjaer A; Mulder WJ; Nahrendorf M
Circ Res; 2015 Oct; 117(10):835-45. PubMed ID: 26394773
[TBL] [Abstract][Full Text] [Related]
10. Plaque rupture and thrombosis are reduced by lowering cholesterol levels and crystallization with ezetimibe and are correlated with fluorodeoxyglucose positron emission tomography.
Patel R; Janoudi A; Vedre A; Aziz K; Tamhane U; Rubinstein J; Abela OG; Berger K; Abela GS
Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):2007-14. PubMed ID: 21817102
[TBL] [Abstract][Full Text] [Related]
11. Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI.
Li X; Bauer W; Israel I; Kreissl MC; Weirather J; Richter D; Bauer E; Herold V; Jakob P; Buck A; Frantz S; Samnick S
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1661-7. PubMed ID: 24903095
[TBL] [Abstract][Full Text] [Related]
12. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine.
Hellberg S; Silvola JM; Kiugel M; Liljenbäck H; Metsälä O; Viljanen T; Metso J; Jauhiainen M; Saukko P; Nuutila P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
Cardiovasc Diabetol; 2016 Feb; 15():26. PubMed ID: 26852231
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging.
Vucic E; Dickson SD; Calcagno C; Rudd JH; Moshier E; Hayashi K; Mounessa JS; Roytman M; Moon MJ; Lin J; Tsimikas S; Fisher EA; Nicolay K; Fuster V; Fayad ZA
JACC Cardiovasc Imaging; 2011 Oct; 4(10):1100-9. PubMed ID: 21999870
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive assessment of hypoxia in rabbit advanced atherosclerosis using ¹⁸F-fluoromisonidazole positron emission tomographic imaging.
Mateo J; Izquierdo-Garcia D; Badimon JJ; Fayad ZA; Fuster V
Circ Cardiovasc Imaging; 2014 Mar; 7(2):312-20. PubMed ID: 24508668
[TBL] [Abstract][Full Text] [Related]
15. Arterial (18)F-fluorodeoxyglucose uptake reflects balloon catheter-induced thrombus formation and tissue factor expression via nuclear factor-κB in rabbit atherosclerotic lesions.
Yamashita A; Zhao Y; Zhao S; Matsuura Y; Sugita C; Iwakiri T; Okuyama N; Ohe K; Koshimoto C; Kawai K; Tamaki N; Kuge Y; Asada Y
Circ J; 2013; 77(10):2626-35. PubMed ID: 23832535
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.
Tahara N; Kai H; Ishibashi M; Nakaura H; Kaida H; Baba K; Hayabuchi N; Imaizumi T
J Am Coll Cardiol; 2006 Nov; 48(9):1825-31. PubMed ID: 17084257
[TBL] [Abstract][Full Text] [Related]
17. Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model.
Abela GS; Picon PD; Friedl SE; Gebara OC; Miyamoto A; Federman M; Tofler GH; Muller JE
Circulation; 1995 Feb; 91(3):776-84. PubMed ID: 7828306
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis.
Davies JR; Izquierdo-Garcia D; Rudd JH; Figg N; Richards HK; Bird JL; Aigbirhio FI; Davenport AP; Weissberg PL; Fryer TD; Warburton EA
Int J Cardiovasc Imaging; 2010 Jan; 26(1):41-8. PubMed ID: 19784796
[TBL] [Abstract][Full Text] [Related]
19. Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques.
Ogawa M; Magata Y; Kato T; Hatano K; Ishino S; Mukai T; Shiomi M; Ito K; Saji H
J Nucl Med; 2006 Nov; 47(11):1845-50. PubMed ID: 17079818
[TBL] [Abstract][Full Text] [Related]
20. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.
Rudd JH; Myers KS; Bansilal S; Machac J; Rafique A; Farkouh M; Fuster V; Fayad ZA
J Am Coll Cardiol; 2007 Aug; 50(9):892-6. PubMed ID: 17719477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
